Manulife Financial (MFC.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Manulife Financial (MFC.TO)

61.42

+1.50 (2.50%)

as of Sep 3, 2026, 8:00:00 pm Market Open.

1632 watching

Investor Insights

Sep 3, 2026, 12:00 am

This summary was created by AI, based on 27 opinions in the last 12 months.

Manulife Financial (MFC) has garnered a mixture of opinions from analysts following its recent quarterly report, which showcased positive developments despite facing challenges such as a new tax on its products for mainland Chinese residents. The company is noted for its strong presence in Asia and steady growth in its wealth management segment, which remains a highlight in its long-term strategy. However, some experts express caution, labeling MFC as a bit overvalued relative to its earnings growth potential, currently trading over 2x book value. The financial landscape for insurers in Canada appears competitive, with both MFC and its peers like TD exhibiting relatively robust performance, yet the consensus leans toward a cautious approach due to market conditions. Overall, while MFC benefits from high dividends and solid asset management, uncertainties related to its exposure to market fluctuations warrant careful monitoring for potential entry points.

Consensus

Cautious

Valuation

Fair Value

Similar

SLF

BUY ON WEAKNESS

MFC vs. RY MFC shows a nice uptrend, but facing long-term resistance. It's overbought, so enter around $26 during a sell-off. RY's chart is moderately positive with short-term resistance around $110. Not much upside at the current $107. Enter at $102-103.

BUY

Why is this trading at $27 when it should be over $30? MFC is transitioning. Insurance is a very long-tail businesses with products that need a lot of time to pay off (insurance policies). Their wealth management business in Asia is strong. It's been a long haul for MFC, going back to the Great Recession, and have been making slow progress. They are growing their book value. If things continue, they will grow their earnings and generally improve. She's happy to hold it. They're quarterly results are becoming consistent which will drive the stock. Pays a 3.6% yield.

DON'T BUY

Not a quality growth company. MFC is too hard for him to figure out. He'd rather buy a Canadian or American bank like National Bank.

BUY

MFC vs. SLF When he values lifecos, it's on price to book, dividend yield, or price to earnings, rather than price to cash flows. Sun Life trades at a premium. His preferred lifeco is Manulife, because of a discounted valuation plus a better business overall because of its Asian business. Wealth management is also better, and getting a handle on legacy businesses.

TOP PICK

It hit a 52 week high yesterday. There is potential for a resolution for some of their long term holdings. They are growing in Asia, where there are higher margins. It trades at a sizable valuation discount to its peers in the space. Yield 3.63% (Analysts’ price target is $30.33)

BUY

Recent break-out Jan. 23 to mid-April is the lifecos' (and banks') seasonality. The chart is setting up for a break-out as MFC approaches its highs of early-2018. Chart looks very good, and MFC will do pretty well.

TOP PICK

Superb dividend at 3.73%. Earning have steadily been rising and yet the price hasn't budged much in past year. Its rising fair market value is a good sign and it may go higher. (Analysts’ price target is $30.33)

PAST TOP PICK

(A Top Pick Jan 15/19, Up 33%) You never know when is going to have a good year. They had been increasing their dividend on flat performance so the yield going into last year was well over 4%. He thinks the new management team is doing the right things. It is still discounted relative to its peers. We are unlikely to see another year of 33%.

Wealthica Track your Stocks in your Watch List

BUY

It is a good company and he thinks it is going higher. They seem to be on a bit of a roll. You could take some profits if you wanted to.

BUY

MFC vs. CM They were late to get US exposure, which hurt them. Also, there's negativity towards CM's mortgage book. TD and RY remain the top Canadian banks, not CM. TD & RY are investing in tech, the future, which is smart. MFC: The lifecos have done well diversifying into asset management and into Asia. But with low interest rates, pricing insurance gets tougher and limits growth. You own lifecos for Asia and wealth management. Not CM, but buy TD and Royal.

BUY

We had a nice little bottom from August. It is at resistance. $26 has been a resistance since early 2018. As long as the stock market goes higher, it will be good for MFC-T. He likes the insurers over the financials. He only like US financials better that Canadian insurance companies. See his Top Picks today. (Analysts’ price target is $30.00)

COMMENT

Canada has four major life insurance companies. Since the financial crisis, Sun Life aas done the best. He does not see much change at Manulife so would prefer Sun Life.

COMMENT

Enter now for the long term? When interest rates are down, they hurt lifecos. But MFC beat their numbers handily last quarter. Asian operations are strong. He's neutral on insurance companies, because rates are so low. However, their valuation is cheap--but also cheap for so long. In 2020, he'll look at the lifecos again. Problem with lifecos is they're like a black box--you don't know what's inside sometimes.

HOLD

The history of what happened 10 years ago weighs on the minds of institutional investors. It is frustrating. At some point in time they should figure out a way to recognize the value.

BUY

MFC vs. SLF They're both good and relatively safe. They both have asset management businesses. Earnings growth will be 7-11% in 2020, which is far higher than the 1-3% for the banks. Also, they trade at single-digit multiples, cheap. According to book value, SLF is far more expensive, so he prefers MFC. MFC has more upside than SLF, but you're splitting hairs with these two.

Showing 331 to 345 of 2,284 entries

Most Recent Experts

Kim Bolton

Black Swan Dexteritas

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Jim Cramer - Mad Money

CNBC

Dan Rohinton

iA Global Asset Management

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Manulife Financial (MFC.TO)